Subtype-Selective Dopamine Receptor Radioligands for PET Imaging: Current Status and Recent Developments
Authors: Banerjee, A.; Prante, O.
Source: Current Medicinal Chemistry, Volume 19, Number 23, August 2012 , pp. 3957-3966(10)
Publisher: Bentham Science Publishers
Abstract:This review presents a general overview of the subtype-selective dopamine receptor radioligands for in vivo imaging of dopamine receptor expression by positron emission tomography (PET). Besides the 11C- and 18F-labeled radioligands which are already in clinical use, a summary of subtype-selective radioligands which had been studied in vitro and in vivo is provided, which shines light onto the current status and recent developments in this field of radiopharmaceutical research.
Document Type: Research Article
Publication date: August 2012
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.